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Stabilization  of  nucleated  blood  cells by  cell  stabilizing  reagent  (BCT  reagent)  present in  the  Cell-Free
DNA  BCTTM blood  collection  device  and  consequent  prevention  of cell-free  DNA  contamination  by cellular
DNA  during  sample  storage  and  shipping  have  previously  been  reported.  This  study  was conducted  to
investigate  the  effect  of  this  novel  cell  stabilizing  reagent  on  DNA  ampliﬁcation  by PCR as  compared  to
traditional  cell  stabilizing  reagents,  formaldehyde  and  glutaraldehyde.  A  787  bp  long DNA  fragment  from
human  glyceraldehydes-3-phosphate  dehydrogenase  (GAPDH)  gene  was  ampliﬁed  by  PCR  and  used as
model  system.  DNA  samples  and  blood  samples  were  treated  with  BCT  reagent,  0.1%  formaldehyde  orormaldehyde free stabilizing reagent
ell-free DNA BCT reagent
0.1%  glutaraldehyde  at room  temperature.  DNA  ampliﬁcation  was  studied  using  conventional  and  real-
time  quantitative  PCR.  Results  indicate  that  exposure  of DNA  to the BCT  reagent  for up  to 14  days  had
no  effect  on DNA  ampliﬁcation  by PCR as  compared  to the untreated  control  DNA.  However,  there  was
statistically  signiﬁcant  decrease  in DNA  ampliﬁcation  in  the  DNA samples  treated  with formaldehyde
and  glutaraldehyde.  We  conclude  that  the  BCT  reagent  used  in  Cell-Free  DNA  BCT  blood  collection  device
to  prevent  cell-free  DNA  contamination  by cellular  DNA  had  no  effect  on  DNA  ampliﬁcation  by  PCR.
pen ac© 2013  Elsevier  GmbH.  
ntroduction
Cell-Free DNA (cfDNA) present in blood is small fragments of
enomic DNA originated from apoptotic or necrotic cells (Wagner,
012). Cell-free DNA is used as biomarkers in clinical tests such
s prenatal diagnosis of trisomy, prenatal sex determination and
s surrogate markers for cancer diagnosis (Devaney et al., 2011;
shoor et al., 2012; Nicolaides et al., 2012; Tsui and Lo, 2012). One
f the major technical challenges that limit the clinical utility of
fDNA biomarkers is its low abundance in patient blood samples
Lo et al., 1998). Fetal cfDNA in maternal blood and tumor-derived
fDNA in cancer patients constitute <10% of total cfDNA (Lo et al.,
998; Chiu and Lo, 2004). Therefore any increase in background
fDNA concentration after blood drawn due to white blood cell
ysis, further decreases the proportion of fetal or tumor-derived
fDNA in blood thus adversely affecting the detection of cfDNA
Oiomarkers. Consequently, it is important to prevent background
fDNA increase post-phlebotomy due to white blood cell lysis (Lee
t al., 2001; Chiu and Lo, 2004). One way to prevent post blood
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Open access under CC BY-NC-ND license.draw background cfDNA increase is to process the blood sample
immediately after the blood draw, which limits the scope of using
cfDNA in diagnostic methods and particularly in remote locations
(Gordian et al., 2010; Lee et al., 2011). Alternatively cellular DNA
leakage can be prevented by stabilizing the white blood cells. Tra-
ditionally, aldehydes, such as formaldehyde or glutaraldehyde are
used as stabilizing agents (Benchi et al., 2004; Dhallan et al., 2004;
Gavrilov and Razin, 2009; Zhang et al., 2008), however, formalde-
hyde and glutaraldehyde are known to cause damage to DNA in
clinical samples (Karlsen et al., 1994; Quach et al., 2004; Gavrilov
and Razin, 2009). Alcohol based stabilization have been reported as
an alternative to aldehyde based stabilization to improve the yield
and quality of recovered nucleic acids (Hostein et al., 2011; Moelans
et al., 2011). However, to the best of our knowledge, alcohols are not
reported to be used to preserve blood specimens; perhaps because
alcohols tend to precipitate plasma proteins and change the con-
sistency of the blood samples. Our previous studies have shown
that cell stabilizing reagent (BCT reagent) present in Cell-Free DNA
BCTTM blood collection device can stabilize white blood cells in
maternal blood samples thereby preserving the original proportion
of fetal cfDNA in maternal blood for up 14 days at room temper-
cess under CC BY-NC-ND license.ature (Fernando et al., 2010). It has also been shown that this cell
stabilizing reagent can prevent white blood cell lysis induced by
shipping and storage of blood samples at different temperatures
(Hidestrand et al., 2012; Norton et al., 2013). BCT reagent contains
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3EDTA as the anticoagulant and a cell stabilizing reagent cocktail,
hich is free of alcohol and detectable amount of formaldehyde as
emonstrated by our earlier studies based on carbon-13 nuclear
agnetic resonance spectroscopic analysis (Das et al., 2013). This
tudy was designed to investigate the effects of BCT reagent on DNA
mpliﬁcation by polymerase chain reaction and to compare it with
ntreated control DNA and DNA treated with formaldehyde and
lutaraldehyde.
aterials and methods
hemicals  and materials
Cell-Free  DNATM BCT blood collection tubes (BCT) were obtained
rom Streck Inc., Omaha, NE, USA (Cat. No. 218961). K3EDTA blood
ollection tubes were from BD Vacutainer®, Becton Dickinson
Franklin Lakes, NJ, USA). Formaldehyde (Cat. No. BDH0500-1LP)
as purchased from BDH (Epping, NSW, Australia). Glutaralde-
yde (25% solution) was purchased from JT Baker (Phillipsburg, NJ,
SA). SYBR® Green I nucleic acid gel stain, 10,000× in DMSO (Cat.
o. S7563) ﬂuorescent dye was purchased from Life Technologies
Grand Island, NY, USA). Human genomic DNA was purchased from
romega (Madison, WI,  USA). The TaqMan® Universal PCR Master
ix II kits were purchased from Applied Biosystems (Foster City,
A, USA). The iQTM SYBR® Green Supermix (Cat. No. 170-8882) was
urchased from Bio-Rad (Hercules, CA, USA).
lood samples
Blood  donors were recruited with written informed consent
rom Streck Inc., Omaha, NE, USA. This study was approved by the
RB of Methodist Hospital, Omaha, NE, USA. Donors were both male
nd female and presumed to be healthy. All draws were obtained by
enipuncture. After phlebotomy plasma was separated by centrifu-
ation at 22 ◦C at 300 × g for 20 min. The plasma layer was carefully
emoved without disturbing the buffy coat, transferred to a new
ial and then centrifuged at 22 ◦C at 5000 × g for 10 min  to remove
esidual cells.
mpliﬁcation of a 787 bp long DNA fragment from human
lyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene
y PCR
Primers to amplify a 787 bp long DNA fragment from human
APDH gene were designed using PrimerQuest online primer
esign tool from Integrated DNA Technologies’s website. The above
egion of the GAPDH gene was ampliﬁed by PCR using primers
forward) 5′-CTT CAT ACC CTC ACG TAT TCC C-3′ and (reverse) 5′-
CA GTC TTG GAT GAG AAA GG-3′. Primers were purchased from
ntegrated DNA Technologies (Coralville, IA, USA). PCR master mix
nd KOD Hot Start DNA polymerase were purchased from Toyobo
o. (Kitakyushu, Japan). PCR reaction was carried out using a ﬁnal
eaction volume of 50 L according to the manufacturer’s instruc-
ion. The PCR product was puriﬁed using Geneclean® Turbo Kit
MP Biomedicals, LLC, Solon, OH, USA) following the manufacturer’s
rotocol.
ffects of the stabilizing reagents on DNA ampliﬁcation by
onventional  end-point PCR
The 787 bp region from human GAPDH gene was  ampliﬁed and
CR product puriﬁed as previously described. Aliquots (30 L) of
uriﬁed PCR product (31 g/mL) were prepared in quadruplicates.
ne aliquot was treated with 30 L of TE buffer and used as con-
rol. Another 30 L aliquot was treated with 30 L of 0.2% (in TE
uffer) formaldehyde, another with 30 L of 0.2% (in TE buffer)ica 116 (2014) 55–60
glutaraldehyde and remaining aliquot was treated with 30 L of
Cell-Free DNA BCT ﬁxative reagent (Cell-Free DNA BCT ﬁxative
reagent present in a 10 mL  tube was diluted with 4.8 mL TE buffer).
Treated DNA samples and control DNA sample were incubated at
22 ◦C. Portions of DNA samples (20 L) were removed from all four
samples on days 0, 7 and 14. DNA samples collected at each time
point were stored at −80 ◦C until analyzed by conventional PCR.
All samples were thawed and ampliﬁed by PCR using the follow-
ing primers; (forward) 5′-CTT CAT ACC CTC ACG TAT TCC C-3′ and
(reverse) 5′-CCA GTC TTG GAT GAG AAA GG-3′. PCR was carried out
as previously described and 10 L of each PCR product was  elec-
trophoresed on 1% agarose gel and stained with ethidium bromide
along with a 100 bp reference ladder.
Effects of the stabilizing reagents on DNA ampliﬁcation by
real-time  quantitative PCR (qPCR)
The 787 bp long GAPDH DNA fragment was prepared and treated
with three ﬁxative reagents as described for DNA ampliﬁcation by
conventional end-point PCR. Treated DNA samples and control DNA
sample were incubated at 22 ◦C. Portions of 10 L DNA samples
were removed from all four samples on days 0, 1, 3 and 14. DNA
samples collected at each time point were stored at −80 ◦C until
analyzed by qPCR. Primers and probes for the qPCR quantiﬁcation of
GAPDH sequence were designed using PrimerQuest online primer
design tool from Integrated DNA Technologies’ website. The follow-
ing primers and probe were used for the quantiﬁcation of GAPDH
sequence; Forward primer 5′-ACA TGT TCC AAT ATG ATT CCA CCC
ATG G-3′; Reverse primer 5′-ATT TCC ATT GAT GAC AAG CTT CCC
GTT C-3′; Probe 6FAM-ATT TTC CAT GGC ACC GTC AAG GCT GA-
TMRA. Primers and probe were purchased from Integrated DNA
Technologies (Coralville, IA, USA). TaqMan® Universal PCR master
mix was purchased from Applied Biosystems (Foster City, CA, USA).
A serially diluted human genomic DNA (4–0.004 g/mL) solution
was used to plot the standard curves.
Effects of the stabilizing reagents in plasma on DNA
ampliﬁcation by qPCR
For  this study, blood was drawn from 6 healthy donors. K3EDTA
blood collection tubes were from BD Vacutainer® (Becton Dickin-
son, Franklin Lakes, NJ, USA). From each donor, blood was drawn
into three 10 mL K3EDTA tubes and one 10 mL Cell-Free DNA BCT.
One K3EDTA tube with 10 mL  of blood was treated with 0.25 mL  of
4% formaldehyde to get a ﬁnal formaldehyde concentration of 0.1%.
Another K3EDTA tube with 10 mL  of blood was treated with 0.25 mL
of 4% glutaraldehyde to get a ﬁnal glutaraldehyde concentration of
0.1%. The remaining K3EDTA tube was used as control. All four tubes
from each donor were spiked with 787 bp long GAPDH DNA frag-
ment (5.3 ng/tube) which was prepared as previously described.
After addition of DNA fragment all tubes were mixed well by invert-
ing 10 times and stored at 22 ◦C. Aliquots (2 mL)  of blood were
removed from each tube at days 0, 3, 7 and 14. Plasma was  separated
by centrifugation as described previously. Plasma samples were
stored at −80 ◦C until plasma DNA was extracted and analyzed by
qPCR assay for GAPDH sequence. Plasma DNA was extracted using
the QIAamp® Circulating Nucleic Acid Kit (Qiagen, Santa Clarita, CA,
USA) following the manufacturer’s recommended protocol. Quanti-
tative PCR for GAPDH sequence was carried out as described above.
Effects of the stabilizing reagents on DNA double-helix
ﬂuorescenceThe 787 bp region from human GAPDH gene was  ampliﬁed and
PCR product was  puriﬁed as described above. Four 30 L aliquots of
puriﬁed PCR product (0.4 g/mL) were prepared and treated with
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Fig. 1. Effect of various stabilizing reagents on DNA ampliﬁcation by conventional end point PCR. DNA samples were treated with stabilizing reagents as previously described
and  untreated and treated DNA was ampliﬁed using primers for human GAPDH gene as described in the “Materials and methods” section. (A) Agarose gel electrophoresis of
PCR  products ampliﬁed from DNA treated with stabilizing reagents for 2 h. Lane 1, untreated control DNA; Lane 2, DNA treated with BCT reagent; Lane 3, DNA treated with
0.1%  formaldehyde; Lane 4, DNA treated with 0.1% of glutaraldehyde. (B) Agarose gel electrophoresis of PCR products ampliﬁed from DNA treated with stabilizing reagents for
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blood were removed from each tube at indicated time points, and
plasma DNA was extracted and quantiﬁed by qPCR. Fig. 3 shows the
effects of ﬁxative reagents on plasma DNA concentration. Plasma
DNA concentration in untreated control and BCT reagent-treated
Fig. 2. Effect of various stabilizing reagents on DNA ampliﬁcation by qPCR. DNA
samples  were treated with stabilizing reagents as previously described. Untreated
and  treated DNA samples were ampliﬁed using primers and probe for human GAPDH
gene by qPCR as described in the “Materials and methods” section. A standard
curve  was constructed using a serially diluted DNA (4–0.004 g/mL) solution for
the quantiﬁcation. Over time, a statistically signiﬁcant decrease in the DNA concen- days. Lane 1, untreated control DNA; Lane 2, DNA treated with BCT reagent; Lane 3
C) Agarose gel electrophoresis of PCR products ampliﬁed from DNA treated with s
CT  reagent; Lane 3, DNA treated with 0.1% formaldehyde; Lane 4, DNA treated wit
xatives as described above. Portions of DNA samples (12.5 L)
ere removed from all four samples on days 0, 7 and 14. DNA
amples collected at each time point were stored at −80 ◦C until
nalyzed by ﬂuorescence spectroscopy. Thawed DNA (12.5 L)
amples were transferred to a 96 well PCR microplate and mixed
ith 12.5 L of diluted (6× in TE buffer) SYBR® Green I dye (Life
echnologies, Grand Island, NY, USA). The ﬂuorescence was  mea-
ured using a Bio-Rad IQ5 thermocycler.
esults
ffect of the stabilizing reagents on DNA ampliﬁcation by
onventional  end-point PCR
DNA samples were treated with the three ﬁxative reagents as
escribed in the “Materials and methods” section. One untreated
ample was used as control. All samples were incubated at 22 ◦C
nd an aliquot of DNA was removed from each sample on days 0, 7
nd 14 for PCR. According to Fig. 1A, at day 0, untreated DNA (lane 1)
nd BCT reagent treated DNA (lane 2) showed PCR bands with sim-
lar intensities. However, DNA treated with formaldehyde (lane 3)
roduced a lower intensity PCR band compared to untreated DNA.
lutaraldehyde-treated DNA (lane 4) did not appear to be ampli-
ed by PCR as no band was detected on the agarose gel. These data
uggests that complete inhibition of PCR by glutaraldehyde. Fig. 1B
hows results for day 7 samples. Untreated sample (lane 1) and BCT
eagent treated sample (lane 2) showed PCR bands comparable to
ay 0 bands. There were no bands for formaldehyde treated (lane 3)
nd glutaraldehyde treated (lane 4) samples. Fig. 1C shows results
or day 14 samples. A pattern similar to day 7 was observed for
ay 14 samples. Untreated sample (lane 1) and BCT reagent-treated
ample (lane 2) were PCR ampliﬁed and DNA bands appeared to be
f similar intensities. No bands were observed for formaldehyde
reated (lane 3) and glutaraldehyde treated (lane 4) samples.
ffect  of the stabilizing on DNA ampliﬁcation by qPCR
DNA  samples were prepared and treated with ﬁxative reagents
s described in the “Materials and methods” section. All samples
ere incubated at 22 ◦C and an aliquot of DNA was removed from
ach sample on days 0, 7 and 14 for qPCR. Fig. 2 demonstrates
he effect of the three ﬁxative reagents on DNA concentration, treated with 0.1% formaldehyde; Lane 4, DNA treated with 0.1% of glutaraldehyde.
ing reagents for 14 days. Lane 1, untreated control DNA; Lane 2, DNA  treated with
 glutaraldehyde.
as  determined by qPCR. Untreated control DNA  samples showed
a slight but statistically signiﬁcant decrease in DNA concentra-
tion only at day 7. DNA concentration in DNA samples treated
with BCT reagent did not change over the 14 day time period.
However, statistically signiﬁcant decreases in DNA concentration
were observed in DNA samples treated with formaldehyde and
glutaraldehyde over a 14 day period.
Effect of the stabilizing reagents in plasma on DNA
ampliﬁcation by qPCR
DNA  fragment ampliﬁed from GAPDH gene, was spiked into
blood samples as described in the “Materials and methods” section.
Blood was  treated with ﬁxative reagents as described. Aliquots oftration for DNA samples treated with 0.1% formaldehyde and 0.1% glutaraldehyde
was  detected. Control and BCT reagent-treated DNA showed no change in DNA con-
centration except for control DNA at day 7 where there was a slight but statistically
signiﬁcant  decrease. Error bars indicates SD, N = 6 (*p < 0.05, **p < 0.005, ***p < 0.0005
by the paired Student’s t-test).
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Fig. 3. Effect of various stabilizing reagents in plasma on DNA ampliﬁcation by qPCR.
Blood was  drawn from 6 donors, treated with stabilizing reagents and spiked with a
human GAPDH DNA fragment as described in the “Materials and methods” section.
Blood samples were stored at 22 ◦C and aliquots of blood were removed from each
sample at 2 h, 3 days, 7 days and 14 days and plasma was separated. Plasma DNA
was extracted and DNA for human GAPDH gene fragment was  ampliﬁed by qPCR, as
described in the “Materials and methods” section. A standard curve was constructed
using  a serial dilution of DNA (4–0.004 g/mL) solution for the quantiﬁcation. Over
time, a statistically signiﬁcant decrease in the DNA concentration for blood samples
treated with 0.1% formaldehyde and 0.1% glutaraldehyde was  observed. Control and
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tCT reagent-treated blood samples showed no change in DNA concentration. Error
ars indicates SD, N = 6 (*p < 0.0005, **p < 0.00005, by the paired Student’s t-test).
lood samples did not changed during 14 days of incubation at
2 ◦C. Plasma DNA concentration in blood samples treated with
ormaldehyde and glutaraldehyde showed a gradual, statistically
igniﬁcant decrease over the 14 days of incubation at 22 ◦C.
ffects of the stabilizing reagents on DNA double-helix
uorescence
To study the effect of ﬁxative reagents on double-stranded DNA
tructure, DNA was exposed to ﬁxatives for various time periods.
ig. 4 shows the effect of the ﬁxative reagents on DNA. Untreated
NA and BCT reagent-treated DNA, showed no statistically signif-
cant change in ﬂuorescence intensity over a 14 day time period.
he ﬂuorescence intensities of DNA samples treated with formalde-
yde and glutaraldehyde decreased signiﬁcantly (*p < 0.001 and
*p < 0.0001) over a 14 day time period.
iscussion
Minimizing  background DNA concentration by preventing cel-
ular DNA leakage is critical in cell-free DNA based diagnostic
rocedures. Cellular DNA leakage are usually prevented by stabiliz-
ng the nucleated blood cells using various cell stabilizing reagents
uch as Cell-Free DNA BCT reagent (BCT reagent) or formalde-
yde (Benchi et al., 2004; Dhallan et al., 2004; Zhang et al., 2008;
avrilov and Razin, 2009; Fernando et al., 2010). However, many
esearchers have also reported that DNA recovered from formalde-
yde treated tissue samples are damaged and are not suitable for
olecular assay methods such as PCR (Karlsen et al., 1994; Quach
t al., 2004; Gavrilov and Razin, 2009). Karlsen and colleagues have
hown that exposure of cells and tissues to formaldehyde caused
 time dependent damage of DNA resulting in erroneous and non-
peciﬁc ampliﬁcation (Karlsen et al., 1994). In our previous study,
e have shown that BCT reagent has no free formaldehyde using
13-NMR spectroscopy (Das et al., 2013). In this present study we
nvestigated the effect of BCT reagent on DNA ampliﬁcation and
ompared it to the effects of formaldehyde and glutaraldehyde. The
xperiments described in this manuscript were conducted with a
87 bp long DNA fragment ampliﬁed from GAPDH gene by PCR.
NA in solution was exposed to BCT reagent, formaldehyde or glu-
araldehyde at room temperature. DNA samples that were exposedica 116 (2014) 55–60
to  stabilizing reagents were ampliﬁed using both conventional
PCR and qPCR. As shown in Fig. 1, data obtained using conven-
tional PCR support observations made by Karlsen and colleagues.
In our experiments formaldehyde and glutaraldehyde treated DNA
showed a time dependent decrease in DNA ampliﬁcation indicat-
ing that both formaldehyde and glutaraldehyde caused damage to
DNA that adversely affect the DNA ampliﬁcation by PCR. In contrast,
DNA treated with BCT reagent showed no change in ampliﬁcation
as compared to initial and untreated DNA samples for up to 14 days
at room temperature. This observation shows that BCT reagent did
not cause any damage to DNA.
Quantitative real-time PCR results (Fig. 2) are also in accordance
with the results obtained by conventional PCR. Untreated control
DNA samples and DNA samples treated with BCT reagent showed
no change in ampliﬁcation up to 14 days at room temperature
indicating that BCT reagent did not cause any damage to DNA. How-
ever, DNA samples treated with formaldehyde and glutaraldehyde
showed a time dependent decrease in DNA ampliﬁcation indicating
deleterious effects of these stabilizing agents on DNA.
We  have also studied the effect of formaldehyde and glutaralde-
hyde on PCR. For conventional PCR experiments we used 3 L of
formaldehyde or glutaraldehyde treated DNA in a 50 L of PCR
reaction which gave ﬁnal formaldehyde and glutaraldehyde con-
centrations of 0.006%. Formaldehyde and glutaraldehyde, at these
concentrations did not inhibit PCR ampliﬁcation of DNA (data not
shown). Therefore, the time dependent inhibition of PCR ampliﬁ-
cation in the formaldehyde and glutaraldehyde treated samples is
due to DNA damage caused by these chemicals.
The qPCR results obtained from plasma samples spiked with
787 bp DNA fragment also showed results similar to our previ-
ous qPCR experiments where treatment of DNA with stabilizing
reagents were carried out in TE buffer solutions. As Fig. 3
illustrates, control DNA and BCT reagent-treated DNA have
similar ampliﬁcation proﬁles through day 14 post treatment.
Formaldehyde-treated DNA samples had decreasing ampliﬁcation
with time. Glutaraldehyde-treated DNA samples had similar ampli-
ﬁcation pattern to formaldehyde up to day 1 and by day 7 there was
no detectable ampliﬁcation.
SYBR  Green dye is an intercalating dye which shows strong
ﬂuorescence when bound to a double helical DNA (Kailasam and
Rogers, 2007). Formation of the DNA double helix requires intact
DNA functional groups in complementary DNA strands. Any chem-
ical modiﬁcation to DNA functional groups can inhibit DNA double
helix formation. Therefore, denaturing DNA with chemically modi-
ﬁed functional groups, using a heat treatment, inhibits reformation
of DNA double helix upon cooling which can be indicated by ﬂuores-
cence spectroscopy (Kailasam and Rogers, 2007). Our  results (Fig. 4)
indicate that formaldehyde- and glutaraldehyde-treated DNA sam-
ples show gradually decreasing ﬂuorescence intensity over time,
whereas BCT reagent-treated DNA sample showed no detectable
decline in ﬂuorescence intensity. Formaldehyde or glutaraldehyde
reacts with the amine groups of DNA base pairs (Chaw et al., 1980;
Huang and Hopkins, 1993; Lu et al., 2010). Amine and carbonyl
groups of the complementary base pairs participate in H-bonding
holding two DNA complementary strands in a helical fashion. Thus
any modiﬁcation on the amine group can cause interruption to
the H-bonding and damage double helical conﬁrmation. There-
fore, the decrease in DNA-SYBR Green ﬂuorescence intensities, with
formaldehyde- and glutaraldehyde-treatment, indicate decreasing
double helical DNA concentration and chemical modiﬁcation of
DNA. Conversely, upon treatment with BCT reagent, the ﬂuores-
cence intensity of DNA-SYBR Green complex remains similar. This
suggests a chemically unaltered DNA double helical structure.
This  study was  conducted with a 787 bp long DNA fragment
ampliﬁed from GAPDH gene by PCR. Cell-free DNA  present in
plasma is known to be signiﬁcantly smaller than this DNA fragment.
K. Das et al. / Acta Histochem
Fig. 4. Effect of various stabilizing reagents on the ﬂuorescence intensity of SYBR
Green-DNA double helix complex. DNA was  treated with stabilizing reagents as
described in the “Materials and methods” section. Aliquots were removed from each
incubation mixture at 2 h, day 7 and day 14, mixed with SYBR Green dye and ana-
lyzed on the iQ5 thermo-cycler as described in the “Materials and methods” section.
Control and BCT reagent-treated DNA showed no change in ﬂuorescence over time.
DNA samples treated with 0.1% formaldehyde and 0.1% glutaraldehyde showed a
statistically signiﬁcant decrease in ﬂuorescence over time. The y-axis represents
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Celative  ﬂuorescence units. Error bars indicate SD, N = 6 (*p < 0.05, **p < 0.005 by the
aired Student’s t-test).
ccording to published data cfDNA fragments present in human
lood are <200 bp long (Lo et al., 1998; Chan et al., 2004; Zheng
t al., 2012). It would be interesting to study the effect of these
tabilizing reagents on smaller DNA fragments with less than 200
ps. In our future experiments we hope to investigate the effects of
hese stabilizing reagents on ampliﬁcation of native cfDNA present
n blood samples instead of spiked DNA fragments.
In this study, we provide experimental evidence that BCT
eagent, which has been previously shown to be able to stabilize
hite blood cells in blood samples, has no effect on DNA ampliﬁ-
ation when DNA was exposed to the reagent for up to 14 days at
oom temperature.
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